Dossier
Recordati
Coverage of Recordati in the Nexus archive.
- GBL Backs CVC Offer to Buy Italy’s Recordati for $12 Billion
CVC has made a $12 billion offer to acquire Recordati, an Italian pharmaceutical company, with backing from GBL (a major shareholder). This represents a significant acquisition in the healthcare and pharmaceutical sector.
- CVC Said to Seek Partners to Back €10.9 Billion Recordati Deal
CVC Capital Partners is seeking partners to support its €10.9 billion acquisition deal for Recordati. The transaction represents a significant investment in the healthcare sector.